Molecular imaging for scintigraphic detection and localization of primary and metastatic neuroendocrine tumors bearing somatostatin receptors.
Sensitivity for carcinoid 89%, gastrinoma 100%, glucagonoma 100%, VIPoma 100%, Insulinoma 42%, medullary thyroid carcinoma 67%, pheochromocytoma 86%, pituitary adenoma 71% small cell lung cancer 100% and Paraganglioma 100%.